The Molecular Perspective: Cyclooxygenase-2 (a fatty acid, more snakelike than spidery, which is clipped from membrane lipids) is converted into prostaglandins by the enzyme cyclooxygenase (COX), also known as prostaglandin H 2 synthase. This enzyme actually contains two active sites, a cyclooxygenase and a peroxidase, performing the first two chemical reactions of prostaglandin synthesis (Fig. 1) . Aspirin arrests the first reaction, insinuating itself into the deep cyclooxygenase active site and bonding directly to a serine amino acid. This glues the drug in place, effectively blocking the entry of arachidonic acid.
The connection between overactive cyclooxygenases and cancer is an area of active study. Two similar forms of cyclooxygenase are constructed by our cells: COX-1 is found in nearly every cell and is used for basic housekeeping functions, and COX-2 is found in specialized cells, where it is synthesized on demand to assist with the process of inflammation. This inducible form of the enzyme, COX-2, has been implicated in cancer progression. Several mechanisms have been proposed. Side effects of the cyclooxygenase reaction may be the problem. Many xenobiotic ("strange biological") compounds, such as aflatoxin, are oxidized by the enzyme, forming potent mutagens. This may be particularly important in the colon, where cells are exposed to many strange molecules in the diet. Or, the prostaglandins themselves may be the problem. They degrade into mutagenic compounds such as malondialdehyde, which can form harmful adducts with DNA. An overabundance of prostaglandins may also send an improper cellular signal, stimulating cell growth inappropriately or reducing the cleansing effect of apoptosis (programmed cell death).
The search is on for effective drugs to block COX-2, while leaving the essential COX-1 enzymes untouched. Aspirin is too harsh for long-term use in chemoprevention. It blocks COX-1 as well as COX-2, disrupting stomach and kidney function as the normal levels of prostaglandins are disturbed. Subtle differences between the two enzymes are currently being explored, and oddlyshaped molecules created to favor the contours of the proper target. 
